EUVIMEDEUVIMED entdecken
Crossref

Therapeutic drug monitoring of medical cannabis in pediatrics: Il monitoraggio terapeutico della Cannabis medica nei pazienti pediatrici: l’esperienza dell’Istituto Giannina Gaslini

Alessia Cafaro, Federica Pigliasco, Sebastiano Barco, Riva A., Pasquale Striano, Manfredini L., Barabino P., Mattioli F., Simona Pichini, Busardo F. P., Cangemi G.

CINECA IRIS Institutial Research Information System (University of Genoa) · 01.01.2023

DOI: 10.19186/bc_2023.038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CINECA IRIS Institutial Research Information System (University of Genoa), erschienen am 01.01.2023. Verfasst von Alessia Cafaro und 10 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The growing interest in medical Cannabis-based therapies has increased in recent years and treatment of drug-resistant epilepsy is one of the most relevant applications. In Italy, the use of medical Cannabis is regulated by Ministerial Decree 9/11/2015. Medical Cannabis consists of dried female flowering tops that contain, among others, at least 90 cannabinoids. D9-tetrahydrocannabinol (THC) is the main psychotropic compound and cannabidiol (CBD) is the main non-psychotropic component. In recent years, a plant-derived pharmaceutical formulation of purified CBD in oral solution (Epidiolex®) has been approved as adjunctive therapy in combination with clobazam for drug-resistant seizures associated with Dravet or Lennox-Gastaut syndrome. As of 2017, several Cannabis preparations, both magistral (oils and decoctions) and Epidyolex®, have been prescribed at Giannina Gaslini Pediatric Institute. To meet the clinical and regulatory needs, several Ultra High Performance Liquid Chromatography coupled to tandem mass spectrometry (UHPLC-MS/MS) methods have been developed and validated in our laboratory according to international guidelines for the validation of bioanalytical methods for the quantification of CBD, THC, cannabidiolic acid (CBD-A), tetrahydrocannabinolic acid (THC-A) and their main metabolites from various matrices (decoctions, oil preparations, plasma, volumetric absorptive microsampling devices). Results highlight the high inter-individual variability and large differences in bioavailability between purified and galenic preparations which underscore the need to implement Therapeutic Drug Monitoring (TDM) for personalization of medical Cannabis treatments.

Schlagwörter

medical cannabistherapeutic drug monitoringpediatric patientsdrug-resistant epilepsycannabidioltetrahydrocannabinolcannabidiolic acidtetrahydrocannabinolic acidUHPLC-MS/MS method validationbioanalytical methods

Zitieren

APA

Cafaro, A., Pigliasco, F., Barco, S., A., R., Striano, P., L., M., P., B., F., M., Pichini, S., P., B. F., & G., C. (2023). Therapeutic drug monitoring of medical cannabis in pediatrics: Il monitoraggio terapeutico della Cannabis medica nei pazienti pediatrici: l’esperienza dell’Istituto Giannina Gaslini. CINECA IRIS Institutial Research Information System (University of Genoa). https://doi.org/10.19186/bc_2023.038

Vancouver

Cafaro A, Pigliasco F, Barco S, A. R, Striano P, L. M, et al. Therapeutic drug monitoring of medical cannabis in pediatrics: Il monitoraggio terapeutico della Cannabis medica nei pazienti pediatrici: l’esperienza dell’Istituto Giannina Gaslini. CINECA IRIS Institutial Research Information System (University of Genoa). 2023. doi:10.19186/bc_2023.038

BibTeX
@article{Cafaro2023,
  author = {Cafaro, Alessia and Pigliasco, Federica and Barco, Sebastiano and A., Riva and Striano, Pasquale and L., Manfredini and P., Barabino and F., Mattioli and Pichini, Simona and P., Busardo F. and G., Cangemi},
  title = {Therapeutic drug monitoring of medical cannabis in pediatrics: Il monitoraggio terapeutico della Cannabis medica nei pazienti pediatrici: l’esperienza dell’Istituto Giannina Gaslini},
  journal = {CINECA IRIS Institutial Research Information System (University of Genoa)},
  year = {2023},
  doi = {10.19186/bc_2023.038}
}
Kostenlos starten →